Smith, Moore & Co. Sana Biotechnology, Inc. Transaction History
Smith, Moore & Co.
- $1.17 Billion
- Q3 2025
A detailed history of Smith, Moore & Co. transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Smith, Moore & Co. holds 11,250 shares of SANA stock, worth $44,887. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,250
Previous 22,500
50.0%
Holding current value
$44,887
Previous $61,000
36.07%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding SANA
# of Institutions
194Shares Held
126MCall Options Held
194KPut Options Held
353K-
Flagship Pioneering Inc. Cambridge, MA25MShares$99.8 Million32.83% of portfolio
-
Baillie Gifford & CO11.4MShares$45.6 Million0.03% of portfolio
-
Black Rock Inc. New York, NY11MShares$44.1 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$40.6 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.13MShares$36.4 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $759M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...